cra). The subjects had a mean age of 31 years. Eleven (42%) were male, including 2 babies born to HIV-1-seropositive mothers, and 15 (58%) were female. Informed consent was obtained from each individual (from mothers or guardians in the case of babies) and 10 ml of whole blood (<5 ml in the case of babies) was collected in EDTA tubes. This was then processed for plasma/serum and peripheral blood monocyte cells (PBMCs). All plasma samples were initially screened for HIV antibody status by particle agglutination (PA) test (Serodia HIV-1/2; Fujirebio, Tokyo, Japan). Reactive specimens were subsequently confirmed by synthetic peptide-based immunoassay (PEPTI-LAV 1-2) or Western blot (WB) analysis (New Lav Blot 1-2) (both kits from Sanofi Diagnostics Pasteur, Marnes-la-Coquette, France). The 
